Masimo, a medical technology company that develops and manufactures noninvasive patient monitoring technologies, has launched a new sub-45 mW signal extraction pulse oximetry platform - MS-2040.
The platform uses nearly a third of the power and half of the physical board size of previously available Signal Extraction Pulse Oximetry solutions.
Masimo claims MS-2040 provides the same Measure-Through Motion and Low Perfusion oxygen saturation (SpO2), pulse rate, and perfusion index (PI) measurement capabilities of Masimo SET pulse oximetry, in addition to Pleth Variability Index (PVI).
Embedded within a completely self-contained patient cable, the ‘board-in-cable’ solution provides external Masimo SET pulse oximetry capabilities for existing devices that do not presently offer an integrated pulse oximetry solution.
This affords medical equipment manufacturers a simpler way to add Masimo SET pulse oximetry as an external (oximeter outside) option and enables a wide range of handheld and patient-wearable application possibilities.
Masimo Worldwide OEM Business and Corporate Development president Rick Fishel said reducing the power usage profile and physical size of their circuit boards enables Masimo and its OEM partners to design smaller, lighter, and more portable monitoring devices with the high performance pulse oximetry capabilities clinicians need for successful use in these new sites and applications.